{"transactions":[{"id":4782,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-09-04T21:19:25.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":5641,"price":20.0778,"value":113258.8698,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 5, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $20.0778 and the range of prices were between $20.00 and $20.1696. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":398429,"source":{"system":"sec-edgar","filing":"0002048593-26-000010","document":"form4-09042026_090921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048593/000204859326000010/form4-09042026_090921.xml","form_type":"4"}},{"id":3385,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-09-03T22:15:05.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":16867,"price":19.1131,"value":322380.6577,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":404070,"source":{"system":"sec-edgar","filing":"0002048593-26-000009","document":"form4-09032026_060901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048593/000204859326000009/form4-09032026_060901.xml","form_type":"4"}},{"id":751750,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-06-03T22:00:08.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":16872,"price":12.6071,"value":212706.9912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":420937,"source":{"system":"sec-edgar","filing":"0002048593-26-000006","document":"form4-06032026_060601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204859326000006/form4-06032026_060601.xml","form_type":"4"}},{"id":843897,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-13T20:15:18.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":287944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":287944,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":287944},"source":{"system":"sec-edgar","filing":"0002048593-26-000003","document":"form4a-03132026_040309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204859326000003/form4a-03132026_040309.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":867173,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-03T23:45:07.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":184837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":184837,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":184837},"source":{"system":"sec-edgar","filing":"0002048593-26-000001","document":"form4-03032026_060302.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204859326000001/form4-03032026_060302.xml","form_type":"4"}},{"id":867172,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:07.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":3384,"price":12.3616,"value":41831.6544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":437809,"source":{"system":"sec-edgar","filing":"0002048593-26-000001","document":"form4-03032026_060302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204859326000001/form4-03032026_060302.xml","form_type":"4"}},{"id":867171,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:07.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":343269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":441193,"source":{"system":"sec-edgar","filing":"0002048593-26-000001","document":"form4-03032026_060302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204859326000001/form4-03032026_060302.xml","form_type":"4"}},{"id":980311,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-12-04T21:20:04.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":3278,"price":29.3359,"value":96163.0802,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":97924,"source":{"system":"sec-edgar","filing":"0002048593-25-000005","document":"form4-12042025_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204859325000005/form4-12042025_041201.xml","form_type":"4"}},{"id":1047918,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-09-04T22:45:15.000Z","date":"2025-09-02","kind":"sale","planned":false,"acquired":false,"shares":3359,"price":18.8632,"value":63361.4888,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":101202,"source":{"system":"sec-edgar","filing":"0001415889-25-023746","document":"form4-09042025_060910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023746/form4-09042025_060910.xml","form_type":"4"}},{"id":1122933,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-06-04T23:30:09.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":311,"price":18.691,"value":5812.901,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $18.691 and the range of prices were between $18.69 and $18.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":104561,"source":{"system":"sec-edgar","filing":"0001415889-25-015666","document":"form4-06042025_070601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925015666/form4-06042025_070601.xml","form_type":"4"}},{"id":1122932,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-06-04T23:30:09.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":2185,"price":18.1489,"value":39655.3465,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $18.1489 and the range of prices were between $17.62 and $18.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":104872,"source":{"system":"sec-edgar","filing":"0001415889-25-015666","document":"form4-06042025_070601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925015666/form4-06042025_070601.xml","form_type":"4"}},{"id":1122931,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-06-04T23:30:09.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":943,"price":17.028,"value":16057.404,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $17.028 and the range of prices were between $16.62 and $17.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":107057,"source":{"system":"sec-edgar","filing":"0001415889-25-015666","document":"form4-06042025_070601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925015666/form4-06042025_070601.xml","form_type":"4"}},{"id":1235825,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-03T22:45:05.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":163000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025."}],"balance_after":163000,"derivative":{"exercise_price":19.91,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":163000},"source":{"system":"sec-edgar","filing":"0001415889-25-006230","document":"form4-03032025_050301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925006230/form4-03032025_050301.xml","form_type":"4"}},{"id":1235824,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-03-03T22:45:05.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":108000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":108000,"source":{"system":"sec-edgar","filing":"0001415889-25-006230","document":"form4-03032025_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925006230/form4-03032025_050301.xml","form_type":"4"}},{"id":1287414,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:22.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":467944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":467944,"derivative":{"exercise_price":17,"expiration_date":"2035-01-28","underlying":"Common Stock","underlying_shares":467944},"source":{"system":"sec-edgar","filing":"0001415889-25-002822","document":"form4-02032025_080218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002822/form4-02032025_080218.xml","form_type":"4"}},{"id":1287413,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:22.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":54911,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option shall vest in 12 equal monthly installments measured four years after August 15, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":54911,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":54911},"source":{"system":"sec-edgar","filing":"0001415889-25-002822","document":"form4-02032025_080218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002822/form4-02032025_080218.xml","form_type":"4"}},{"id":1287412,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:22.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":494198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth of the shares subject to this option shall vest one year after August 15, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":494198,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":494198},"source":{"system":"sec-edgar","filing":"0001415889-25-002822","document":"form4-02032025_080218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002822/form4-02032025_080218.xml","form_type":"4"}},{"id":1287411,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:22.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":83268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in 12 equal monthly installments measured four years after August 1, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":83268,"derivative":{"exercise_price":7.51,"expiration_date":"2032-07-31","underlying":"Common Stock","underlying_shares":83268},"source":{"system":"sec-edgar","filing":"0001415889-25-002822","document":"form4-02032025_080218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002822/form4-02032025_080218.xml","form_type":"4"}},{"id":1287410,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:22.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":749445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to this option shall vest one year after August 1, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":749445,"derivative":{"exercise_price":7.51,"expiration_date":"2032-07-31","underlying":"Common Stock","underlying_shares":749445},"source":{"system":"sec-edgar","filing":"0001415889-25-002822","document":"form4-02032025_080218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002822/form4-02032025_080218.xml","form_type":"4"}},{"id":1289524,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-31T21:35:51.000Z","date":"2025-01-29","kind":"grant","planned":false,"acquired":true,"shares":467944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":467944,"derivative":{"exercise_price":17,"expiration_date":"2035-01-28","underlying":"Class B Common Stock","underlying_shares":467944},"source":{"system":"sec-edgar","filing":"0001415889-25-002490","document":"form4-01312025_090147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002490/form4-01312025_090147.xml","form_type":"4"}}]}